These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Changes in platelet, granulocyte, and complement activation during cardiopulmonary bypass using heparin-coated equipment. Fukutomi M; Kobayashi S; Niwaya K; Hamada Y; Kitamura S Artif Organs; 1996 Jul; 20(7):767-76. PubMed ID: 8828766 [TBL] [Abstract][Full Text] [Related]
3. Neutrophil adhesion molecule expression during cardiopulmonary bypass with bubble and membrane oxygenators. Gillinov AM; Bator JM; Zehr KJ; Redmond JM; Burch RM; Ko C; Winkelstein JA; Stuart RS; Baumgartner WA; Cameron DE Ann Thorac Surg; 1993 Oct; 56(4):847-53. PubMed ID: 8105757 [TBL] [Abstract][Full Text] [Related]
4. Complement and neutrophil activation during cardiopulmonary bypass: a study in the complement-deficient dog. Gillinov AM; Redmond JM; Winkelstein JA; Zehr KJ; Herskowitz A; Baumgartner WA; Cameron DE Ann Thorac Surg; 1994 Feb; 57(2):345-52. PubMed ID: 7906115 [TBL] [Abstract][Full Text] [Related]
5. Platelet activating factor inhibition reduces lung injury after cardiopulmonary bypass. Zehr KJ; Poston RS; Lee PC; Uthoff K; Kumar P; Cho PW; Gillinov AM; Redmond JM; Winkelstein JA; Herskowitz A Ann Thorac Surg; 1995 Feb; 59(2):328-35. PubMed ID: 7847945 [TBL] [Abstract][Full Text] [Related]
6. Inhibition of neutrophil adhesion during cardiopulmonary bypass. Gillinov AM; Redmond JM; Zehr KJ; Wilson IC; Curtis WE; Bator JM; Burch RM; Reitz BA; Baumgartner WA; Herskowitz A Ann Thorac Surg; 1994 Jan; 57(1):126-33. PubMed ID: 7904144 [TBL] [Abstract][Full Text] [Related]
7. Biocompatibility of heparin-coated circuits used in cardiopulmonary bypass. Pekna M; Borowiec J; Fagerhol MK; Venge P; Thelin S Scand J Thorac Cardiovasc Surg; 1994; 28(1):5-11. PubMed ID: 7939508 [TBL] [Abstract][Full Text] [Related]
8. Heparin-coated circuits reduce the formation of TNF alpha during cardiopulmonary bypass. Yamada H; Kudoh I; Hirose Y; Toyoshima M; Abe H; Kurahashi K Acta Anaesthesiol Scand; 1996 Mar; 40(3):311-7. PubMed ID: 8721461 [TBL] [Abstract][Full Text] [Related]
9. The effects of heparin coated circuits on pulmonary injury. A clinical study. Kazaz H; Oto O; Sariosmanoglu N; Hazan E J Cardiovasc Surg (Torino); 2003 Oct; 44(5):611-5. PubMed ID: 14735048 [TBL] [Abstract][Full Text] [Related]
10. Heparin coating reduces blood cell adhesion to arterial filters during coronary bypass: a clinical study. Borowiec JW; Bylock A; van der Linden J; Thelin S Ann Thorac Surg; 1993 Jun; 55(6):1540-5. PubMed ID: 8512409 [TBL] [Abstract][Full Text] [Related]
11. Heparin-coated equipment reduces complement activation during cardiopulmonary bypass in the pig. Nilsson L; Storm KE; Thelin S; Bagge L; Hultman J; Thorelius J; Nilsson U Artif Organs; 1990 Feb; 14(1):46-8. PubMed ID: 2302076 [TBL] [Abstract][Full Text] [Related]
12. The impact of heparin-coated cardiopulmonary bypass circuits on pulmonary function and the release of inflammatory mediators. de Vroege R; van Oeveren W; van Klarenbosch J; Stooker W; Huybregts MAJM; Hack CE; van Barneveld L; Eijsman L; Wildevuur CRH Anesth Analg; 2004 Jun; 98(6):1586-1594. PubMed ID: 15155310 [TBL] [Abstract][Full Text] [Related]
13. Initiation of white cell activation during cardiopulmonary bypass: cytokines and receptors. Cameron D J Cardiovasc Pharmacol; 1996; 27 Suppl 1():S1-5. PubMed ID: 8938277 [TBL] [Abstract][Full Text] [Related]
14. Deleterious effects of cardiopulmonary bypass on early graft function after single lung allotransplantation: evaluation of a heparin-coated bypass circuit. Francalancia NA; Aeba R; Yousem SA; Griffith BP; Marrone GC J Heart Lung Transplant; 1994; 13(3):498-507. PubMed ID: 8061027 [TBL] [Abstract][Full Text] [Related]
15. Heparin-coated circuits reduce complement activation and inflammatory response to cardiopulmonary bypass. Tamim M; Demircin M; Guvener M; Peker O; Yilmaz M Panminerva Med; 1999 Sep; 41(3):193-8. PubMed ID: 10568115 [TBL] [Abstract][Full Text] [Related]
16. Complement inhibition with soluble complement receptor type 1 in cardiopulmonary bypass. Gillinov AM; DeValeria PA; Winkelstein JA; Wilson I; Curtis WE; Shaw D; Yeh CG; Rudolph AR; Baumgartner WA; Herskowitz A Ann Thorac Surg; 1993 Mar; 55(3):619-24. PubMed ID: 8383955 [TBL] [Abstract][Full Text] [Related]